joint with Functional Cures and the Eradication of HIV
Organizer(s): Nicole A. Doria-Rose, Thumbi Ndung'u and Gunilla Karlsson HedestamDate: March 24 - 28, 2019
Location: Fairmont Chateau Whistler, Whistler, BC, Canada
Despite dramatic progress in prevention and treatment of HIV, the pandemic continues, and two million people are newly infected each year. Thus, the need for a preventive vaccine for HIV is as urgent as ever. Intensive research in basic immunology and virology as well as empirical clinical trial data continues to yield insights that inform vaccine efforts. The 2019 HIV Vaccines conference presents the latest results from human clinical studies of candidate vaccines as well as the use of monoclonal antibodies for prevention; novel HIV neutralizing antibodies and their developmental pathways; T cell functions in killing and B cell help; structural insights and immunogen design; and the intersection of research for HIV eradication/cure with research on HIV vaccines, including interventions after very early antiretroviral therapy. The program also includes a session on the process of bringing candidate vaccines to clinical trial, told from the diverse perspectives of laboratory investigators, industrial production, funders and clinical researchers on the front lines.
Global Health Travel Award Deadline: October 23 2018
Scholarship Deadline: December 5 2018
Discounted Abstract Deadline: December 5 2018
Abstract Deadline: December 18 2018
Discounted Registration Deadline: January 24 2019
We gratefully acknowledge additional support for this conference from:
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
Janssen Vaccines & Prevention BV
We gratefully acknowledge the generous grant for this conference provided by:National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1R13AI143345-01
Funding for this conference was made possible (in part) by 1R13AI143345-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.